title: Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo.
abstract: Lung cancer remains the leading cause of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) represents approximately 80% of total lung cancer cases. The use of non-toxic dietary phytochemicals can be considered as a chemotherapeutic strategy for the management of the NSCLC. Here, we report that grape seed proanthocyanidins (GSPs) induce apoptosis of NSCLC cells, A549 and H1299, in vitro which is mediated through increased expression of pro-apoptotic protein Bax, decreased expression of anti-apoptotic proteins Bcl2 and Bcl-xl, disruption of mitochondrial membrane potential, and activation of caspases 9, 3 and poly (ADP-ribose) polymerase (PARP). Pre-treatment of A549 and H1299 cells with the caspase-3 inhibitor (z-DEVD-fmk) significantly blocked the GSPs-induced apoptosis of these cells confirmed that GSPs-induced apoptosis is mediated through activation of caspases-3. Treatments of A549 and H1299 cells with GSPs resulted in an increase in G1 arrest. G0/G1 phase of the cell cycle is known to be controlled by cyclin dependent kinases (Cdk), cyclin-dependent kinase inhibitors (Cdki) and cyclins. Our western blot analyses showed that GSPs-induced G1 cell cycle arrest was mediated through the increased expression of Cdki proteins (Cip1/p21 and Kip1/p27), and a simultaneous decrease in the levels of Cdk2, Cdk4, Cdk6 and cyclins. Further, administration of 50, 100 or 200 mg GSPs/kg body weight of mice by oral gavage (5 d/week) markedly inhibited the growth of s.c. A549 and H1299 lung tumor xenografts in athymic nude mice, which was associated with the induction of apoptotic cell death, increased expression of Bax, reduced expression of anti-apoptotic proteins and activation of caspase-3 in tumor xenograft cells. Based on the data obtained in animal study, human equivalent dose of GSPs was calculated, which seems affordable and attainable. Together, these results suggest that GSPs may represent a potential therapeutic agent for the non-small cell lung cancer.
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
authors.forename: Tripti
authors.initials: T
authors.lastname: Singh
authors.forename: Som D
authors.initials: SD
authors.lastname: Sharma
authors.forename: Santosh K
authors.initials: SK
authors.lastname: Katiyar
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D053148:Caspase 3 / Q000378:metabolism; D002453:Cell Cycle / Q000187:drug effects; D018797:Cell Cycle Proteins; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D056604:Grape Seed Extract / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects*; D051379:Mice; D044945:Proanthocyanidins / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D023041:Xenograft Model Antitumor Assays
chemical_list: D018797:Cell Cycle Proteins; D056604:Grape Seed Extract; C511402:Grape Seed Proanthocyanidins; D044945:Proanthocyanidins; D053148:Caspase 3
references.citation: Cell. 1994 Nov 18;79(4):573-82
references.pmid: 7954824
references.citation: Science. 1997 Feb 21;275(5303):1132-6
references.pmid: 9027315
references.citation: Biochim Biophys Acta. 2002 Mar 14;1602(1):73-87
references.pmid: 11960696
references.citation: Clin Cancer Res. 2009 Feb 1;15(3):821-31
references.pmid: 19188152
references.citation: Nature. 1995 Mar 9;374(6518):131-4
references.pmid: 7877684
references.citation: FASEB J. 2008 Mar;22(3):659-61
references.pmid: 17942826
references.citation: Ann Thorac Surg. 2004 Apr;77(4):1484-91
references.pmid: 15063303
references.citation: FASEB J. 1994 Jun;8(9):654-60
references.pmid: 8005393
references.citation: Carcinogenesis. 2006 Oct;27(10):2018-27
references.pmid: 16621886
references.citation: Cancer Metastasis Rev. 1992 Sep;11(2):121-39
references.pmid: 1327566
references.citation: Science. 1998 Aug 28;281(5381):1312-6
references.pmid: 9721091
references.citation: Carcinogenesis. 2003 Aug;24(8):1379-88
references.pmid: 12807737
references.citation: Mol Cell Biochem. 1999 Jun;196(1-2):99-108
references.pmid: 10448908
references.citation: J Biol Chem. 1999 Jul 16;274(29):20049-52
references.pmid: 10400609
references.citation: Mol Cancer Ther. 2007 Mar;6(3):995-1005
references.pmid: 17363493
references.citation: J Mol Biol. 1999 Apr 16;287(5):821-8
references.pmid: 10222191
references.citation: Mol Cancer Ther. 2010 Mar;9(3):569-80
references.pmid: 20145019
references.citation: Curr Opin Drug Discov Devel. 2001 Sep;4(5):623-34
references.pmid: 12825457
references.citation: Cell. 1994 Jul 15;78(1):67-74
references.pmid: 8033213
references.citation: Biochem Pharmacol. 1990 Nov 15;40(10):2353-62
references.pmid: 2244936
references.citation: Cell. 1994 Aug 26;78(4):539-42
references.pmid: 8069905
references.citation: Trends Pharmacol Sci. 1992 Jun;13(6):245-51
references.pmid: 1631963
references.citation: Nature. 1997 Feb 13;385(6617):637-40
references.pmid: 9024662
references.citation: Res Commun Mol Pathol Pharmacol. 1997 Feb;95(2):179-89
references.pmid: 9090754
references.citation: Curr Opin Oncol. 1995 Nov;7(6):541-6
references.pmid: 8547403
references.citation: Lung Cancer. 2000 Aug;29(2):91-104
references.pmid: 10963840
references.citation: Oncogene. 1995 Jul 20;11(2):211-9
references.pmid: 7624138
references.citation: Annu Rev Immunol. 1998;16:395-419
references.pmid: 9597135
references.citation: Nat Rev Cancer. 2001 Oct;1(1):82-6
references.pmid: 11900255
references.citation: Cell Prolif. 2000 Oct;33(5):261-74
references.pmid: 11063129
references.citation: Carcinogenesis. 2006 Aug;27(8):1682-91
references.pmid: 16597645
references.citation: Lancet. 2000 Feb 5;355(9202):479-85
references.pmid: 10841143
references.citation: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2345-9
references.pmid: 9122197
references.citation: CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30
references.pmid: 15661684
references.citation: Science. 1998 Aug 28;281(5381):1309-12
references.pmid: 9721092
references.citation: Mol Cancer Ther. 2006 Feb;5(2):296-308
references.pmid: 16505103
references.citation: Cancer Metastasis Rev. 1995 Mar;14(1):3-15
references.pmid: 7606818
references.citation: Planta Med. 1996 Dec;62(6):495-502
references.pmid: 9000880
references.citation: Nature. 1990 Nov 22;348(6299):334-6
references.pmid: 2250705
references.citation: Biochim Biophys Acta. 2004 Mar 1;1644(2-3):133-47
references.pmid: 14996498